β Cell-Specific CD4+ T Cell Clonotypes in Peripheral Blood and the Pancreatic Islets Are Distinct1

Type 1 diabetes is an autoimmune disease mediated by β cell-specific CD4+ and CD8+ T cells. Tracking β cell-specific T cells is one approach to monitor the diabetogenic response in at risk or diabetic individuals. Such analyses, however, are limited to PBL because T cells infiltrating the pancreatic islets are normally inaccessible. A key issue is whether peripheral β cell-specific T cells accurately reflect those cells infiltrating the target tissue. We investigated the properties of CD4+ T cells specific for a mimetic epitope recognized by the BDC2.5 clonotypic TCR in NOD mice. Soluble IAg7-Ig (sIAg7-Ig) multimer complexes covalently linked to a mimetic BDC peptide (sIAg7-mBDC) were used to identify or isolate CD4+ T cells from PBL and the islets of NOD mice. A temporal increase in sIAg7-mBDC binding (g7-mBDC+) T cells corresponding with the progression of β cell autoimmunity was detected in both PBL and islets in NOD female mice. In contrast to T cells in PBL, however, the majority of islet g7-mBDC+ T cells exhibited a type 1 phenotype, and mediated diabetes upon transfer into NOD.scid recipients. TCR-β and CDR-β gene usage of single islet-infiltrating g7-mBDC+ CD4+ T cells from individual NOD mice showed a restricted repertoire dominated by one or two clones typically expressing TCR β-chain variable TRBV-15. In contrast, a distinct and diverse TCR repertoire was detected for PBL-derived g7-mBDC+ T cells. These results demonstrate that PBL and islet CD4+ T cells specific for a given β cell epitope can differ regarding pathogenicity and TCR repertoire.

[1]  Kenji Yoshida,et al.  Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity. , 2003, The Journal of clinical investigation.

[2]  L. Chess,et al.  Characterizing the circulating, gliadin‐specific CD4+ memory T cells in patients with celiac disease: linkage between memory function, gut homing and Th1 polarization , 2006, Journal of leukocyte biology.

[3]  Bhagirath Singh,et al.  Epitope dominance: evidence for reciprocal determinant spreading to glutamic acid decarboxylase in non‐obese diabetic mice , 1998, Immunological reviews.

[4]  Clemencia Pinilla,et al.  Identification of MHC Class II-Restricted Peptide Ligands, Including a Glutamic Acid Decarboxylase 65 Sequence, that Stimulate Diabetogenic T Cells from Transgenic BDC2.5 Nonobese Diabetic Mice1 , 2001, The Journal of Immunology.

[5]  C. Boitard,et al.  Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells , 1987, The Journal of experimental medicine.

[6]  C. Benoist,et al.  TCR-based lineage tracing: no evidence for conversion of conventional into regulatory T cells in response to a natural self-antigen in pancreatic islets , 2007, The Journal of experimental medicine.

[7]  R. Tisch,et al.  Identical β Cell-Specific CD8+ T Cell Clonotypes Typically Reside in Both Peripheral Blood Lymphocyte and Pancreatic Islets1 , 2007, The Journal of Immunology.

[8]  D. Jewell,et al.  In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope , 2000, Nature Medicine.

[9]  Mark M. Davis,et al.  Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Tisch,et al.  T-Cell Promiscuity in Autoimmune Diabetes , 2008, Diabetes.

[11]  D. Monos,et al.  Insulin dependent diabetes mellitus as an autoimmune disease. , 1988, In vivo.

[12]  B. Bisikirska,et al.  TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. , 2005, The Journal of clinical investigation.

[13]  P. van Endert,et al.  Equivalent Specificity of Peripheral Blood and Islet-Infiltrating CD8+ T Lymphocytes in Spontaneously Diabetic HLA-A2 Transgenic NOD Mice1 , 2008, The Journal of Immunology.

[14]  K. Haskins,et al.  Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. , 1990, Science.

[15]  K. Haskins,et al.  Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse. , 2005, Advances in immunology.

[16]  G. Eisenbarth,et al.  Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice , 2005, Nature.

[17]  Thomas B. Kepler,et al.  SoDA: implementation of a 3D alignment algorithm for inference of antigen receptor recombinations , 2006, Bioinform..

[18]  Mark Peakman,et al.  Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. , 2004, The Journal of clinical investigation.

[19]  S. Tafuro,et al.  Progression of autoimmune diabetes driven by avidity maturation of a T-cell population , 2000, Nature.

[20]  K. Lafferty,et al.  T-Lymphocyte Clone Specific for Pancreatic Islet Antigen , 1988, Diabetes.

[21]  J. Peterson,et al.  Transfer of Diabetes in the NOD-scid Mouse by CD4 T-Cell Clones: Differential Requirement for CD8 T-Cells , 1996, Diabetes.

[22]  M. Atkinson,et al.  The pathogenesis of insulin-dependent diabetes mellitus. , 1994, The New England journal of medicine.

[23]  R. Tisch,et al.  Early Autoimmune Destruction of Islet Grafts Is Associated with a Restricted Repertoire of IGRP-Specific CD8+ T Cells in Diabetic Nonobese Diabetic Mice1 , 2006, The Journal of Immunology.

[24]  B. Bergman,et al.  Islet-Specific T-Cell Clones From the NOD Mouse Respond to β-Granule Antigen , 1994, Diabetes.

[25]  D. Finegood,et al.  Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. , 2003, The Journal of clinical investigation.

[26]  J. She.  Faculty Opinions recommendation of Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. , 2003 .

[27]  R. Tisch,et al.  On the Pathogenicity of Autoantigen-Specific T-Cell Receptors , 2008, Diabetes.

[28]  Marion Pepper,et al.  Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. , 2007, Immunity.

[29]  L. Wicker,et al.  Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. , 1988, Journal of immunology.

[30]  B. Arden.  Diversity of novel recombining elements suggests developmentally programmed expression of the T cell receptor α/δ locus , 1992 .

[31]  N. L. La Gruta,et al.  Reliable generation and use of MHC class II:gamma2aFc multimers for the identification of antigen-specific CD4(+) T cells. , 2002, Journal of immunological methods.

[32]  C. Benoist,et al.  Following a diabetogenic T cell from genesis through pathogenesis , 1993, Cell.

[33]  Mark S. Anderson,et al.  The NOD mouse: a model of immune dysregulation. , 2005, Annual review of immunology.

[34]  J. Shabanowitz,et al.  Identification of the β cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[35]  W. Ridgway,et al.  A New Look at MHC and Autoimmune Disease , 1999, Science.

[36]  L. Adorini,et al.  The Frequency of High Avidity T Cells Determines the Hierarchy of Determinant Spreading1 , 2001, The Journal of Immunology.

[37]  R. Tisch,et al.  Insulin-Dependent Diabetes Mellitus , 1996, Cell.

[38]  E. Unanue,et al.  The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. , 1996, Journal of immunology.